Metformin: An Intriguing Protective Agent in Hospitalized Diabetic Patients With Sepsis
- PMID: 35612442
- DOI: 10.1097/CCM.0000000000005480
Metformin: An Intriguing Protective Agent in Hospitalized Diabetic Patients With Sepsis
Comment on
-
Association of Metformin Use During Hospitalization and Mortality in Critically Ill Adults With Type 2 Diabetes Mellitus and Sepsis.Crit Care Med. 2022 Jun 1;50(6):935-944. doi: 10.1097/CCM.0000000000005468. Epub 2022 Feb 7. Crit Care Med. 2022. PMID: 35120041
References
-
- Singer M, Deutschman CS, Seymour CW, et al.: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801–810
-
- Rudd KE, Johnson SC, Agesa KM, et al.: Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study. Lancet 2020; 395:200–211
-
- Koh GC, Peacock SJ, van der Poll T, et al.: The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis 2012; 31:379–388
-
- Tiwari S, Pratyush DD, Gahlot A, et al.: Sepsis in diabetes: A bad duo. Diabetes Metab Syndr 2011; 5:222–227
-
- Purcarea A, Sovaila S: Sepsis, a 2020 review for the internist. Rom J Intern Med 2020; 58:129–137
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
